Article ID Journal Published Year Pages File Type
2565040 Progress in Neuro-Psychopharmacology and Biological Psychiatry 2012 5 Pages PDF
Abstract

Individuals with a history of childhood maltreatment present increased rates of metabolic disturbances, but the underlying mechanisms for such phenomena are poorly understood. This study examined whether the secretion of adipokines, adipocyte-derived inflammation markers closely associated with metabolic disorders, is altered in individuals with a history of childhood maltreatment. The serum levels of inflammatory markers adiponectin and resistin were measured from 147 general population participants who had a history of adverse mental symptoms, and who also reported their experiences of childhood maltreatment. Participants with experiences of childhood maltreatment (n = 30) had lowered levels of serum adiponectin (p = 0.007) and resistin (p = 0.028). The differences in adiponectin levels persisted in multivariate modeling with adjustments for age, gender, and body mass index (OR for each 1 standard deviation decrease in the serum adiponectin level 2.65, 95% CI 1.31–5.35, p = 0.007). Additional adjustments for marital status or a diagnosis of major depressive disorder, or the exclusion of individuals using NSAIDs, oral corticosteroids, or antidepressants did not alter the results. The association between resistin levels and childhood maltreatment did not remain independent in the same models. Our findings suggest that in individuals with previously reported adverse mental symptoms, a history of childhood maltreatment is independently associated with lowered levels of the anti-inflammatory marker adiponectin. This may lead to a lowered anti-inflammatory buffer capacity, which can, in turn, increase the susceptibility to physical and psychological states characterized by pronounced pro-inflammation.

► A history of childhood maltreatment associated with lowered levels of adiponectin. ► No associations were detected with regard to resistin after multivariate modeling. ► Antidepressant or anti-inflammatory drug use exclusions did not alter the findings.

Related Topics
Life Sciences Neuroscience Biological Psychiatry
Authors
, , , , , , , , , , , , ,